Heart Podcast

Therapies for ventricular tachycardia

Dec 16, 2025
Dr. John Sapp, a cardiac electrophysiologist and professor at Dalhousie University, dives deep into the complexities of ventricular tachycardia (VT). He explains the transformation of VT from a sudden death threat to a manageable condition with ICDs. The conversation covers the re-entry mechanisms that cause VT, the benefits and risks of antiarrhythmic drugs, and the evolution of VT ablation techniques. Emerging technologies like larger-footprint catheters showcase the future of treatment, while Sapp shares insights on success rates and increasing procedure complexities.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

VT As A Chronic Disease

  • Ventricular tachycardia (VT) has become a chronic disease thanks to implantable defibrillators that prevent sudden death.
  • Defibrillators transformed invisible sudden deaths into a treated population living with recurrent VT issues.
INSIGHT

Scar Channels Drive Re-Entry VT

  • The commonest VT mechanism in ischemic cardiomyopathy is re-entry via channels in scar tissue.
  • Surviving myocardial channels within scars can permit slow conduction and form re-entrant circuits.
ADVICE

Act Promptly On VT Symptoms

  • Recognize symptoms: palpitations, lightheadedness, syncope, or shocks from an ICD require urgent evaluation.
  • Treat clustered arrhythmias aggressively because multiple events often signify higher risk.
Get the Snipd Podcast app to discover more snips from this episode
Get the app